Clinical Trials

81 enrolled 13 charts

Phase EARLY_PHASE1 Recruiting

Colorectal Neoplasms

NCT05080946 2026-04-01

Using Aspirin to Improve Immunological Features of Ovarian Tumors

100 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05557877 2026-03-31

Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

100 enrolled

Breast

Breast Neoplasms

NCT03654105 2026-03-27

SMILE

Classical hematologyMyeloid

2,000 enrolled

Thoracic

Inflammation, Lung Neoplasms, Motor Activity, Smoking Cessation

NCT05198960 2026-03-20

AVAJAK

Phase 3 Recruiting

1,308 enrolled

Hemorrhage, Polycythemia Vera, Thrombocythemia, Essential, Venous Thromboembolism, Primary Myelofibrosis

NCT02647099 2026-03-13

ALASCCA

Phase 3 Active not recruiting

626 enrolled 14 charts

Phase EARLY_PHASE1 Completed

Colorectal Neoplasms

NCT06378398 2026-03-13

A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy

21 enrolled

Phase 4 Not yet recruiting

Colorectal Neoplasia

NCT07281547 2026-02-18

Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain

25 enrolled

Phase EARLY_PHASE1 Active not recruiting

Endometrial Neoplasms

NCT03771651 2026-02-17

Short Term Aspirin on the Biologic and Immunologic Changes of the Fallopian Tube

18 enrolled

Fallopian Tube Neoplasms

NCT05036109 2026-02-10

DAILY: Vitamin D, Aspirin, ExercIse, Low Saturated Fat Foods StudY in Colorectal Cancer Patients With Minimal Residual Disease

Phase NA Completed

16 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT06728072 2026-02-09

Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer

97 enrolled

Colorectal Neoplasms

NCT04184921 2026-02-03

Combination of Osimertinib and Aspirin to Treat EGFR Mutation NSCLC Patients

Phase 2 Completed

216 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06866964 2026-02-02

ASPIRE

Classical hematologyGenitourinary

35 enrolled

Neoplasms, Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms, Venous Thromboembolism

NCT05056896 2026-01-16

ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension

Phase EARLY_PHASE1 Active not recruiting

161 enrolled

Colorectal Neoplasms

NCT03480776 2026-01-14

ASA in Prevention of Ovarian Cancer (STICs and STONEs)

117 enrolled

Ovarian Cancer Prevention

NCT03079999 2025-12-18

Study of Aspirin in Patients With Vestibular Schwannoma

Phase NA Active not recruiting

97 enrolled

CNS

Neuroma, Acoustic, Neurofibromatosis 2

NCT04188119 2025-12-08

IMpALA

Phase 2 Withdrawn

Breast

Breast Neoplasms

NCT02394769 2025-12-04

ASPIRED

180 enrolled 21 charts

Colorectal Neoplasms

NCT05411718 2025-11-13

A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome

40 enrolled

Colorectal Neoplasms, Hereditary Nonpolyposis, Colorectal Neoplasms

NCT02521285 2025-10-23

Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation

21 enrolled 35 charts

Phase 4 Enrolling by invitation

Adenocarcinoma Of Esophagus, Barrett Esophagus

NCT03244020 2025-10-03

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

2,868 enrolled

Classical hematologySarcoma

Bone Neoplasms, Hematoma, Sarcoma, Venous Thromboembolism

NCT04182100 2025-09-15

Efficacy and Safety of P1101 in Polycythemia Vera Patients for Whom the Standard of Treatment is Difficult to Apply

Phase 2 Completed

29 enrolled 15 charts

Myeloid

Myeloproliferative Disorders, Polycythemia Vera

NCT03899987 2025-08-27

Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery

Phase EARLY_PHASE1 Completed

12 enrolled

Genitourinary

Prostatic Neoplasms

NCT04379999 2025-08-07

Atorvastatin ± Aspirin in Lynch Syndrome Syndrome

43 enrolled

Phase 2/3 Active not recruiting

Colorectal Neoplasms, Hereditary Nonpolyposis

NCT03326791 2025-07-31

ASAC

466 enrolled

Phase 4 Not yet recruiting

Colorectal Neoplasms

NCT06290765 2025-07-31

PV

70 enrolled

Myeloid

Myeloproliferative Disorders, Polycythemia Vera

NCT03805932 2025-07-24

Moxetumomab Pasudotox-tdfk (Lumoxiti(TM)) and Either Rituximab (Rituxan(R)) or Ruxience for Relapsed Hairy Cell Leukemia

Phase 1 Active not recruiting

18 enrolled 15 charts

Other hematologic neoplasm

Leukemia, Hairy Cell

NCT06580223 2025-07-18

Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma

Phase 3 Not yet recruiting

530 enrolled

Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism

NCT03819101 2025-06-26

PEACE-4

Phase 3 Recruiting

1,210 enrolled

Genitourinary

Prostatic Neoplasms

NCT02804815 2025-06-10

Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours

Phase 3 Active not recruiting

11,000 enrolled

BreastGastrointestinalGenitourinary

Breast Neoplasms, Neoplasms, Prostatic Neoplasms, Recurrence, Colorectal Neoplasms

NCT02467582 2025-05-16

Adjuvant Aspirin Treatment for Colon Cancer Patients

Phase 3 Terminated

1,040 enrolled 11 charts